US Measles Cases Reach 5,182 in 2026, Highest Annual Total Since 1991

US Measles Cases Reach 5,182 in 2026 Highest Annual Total Since 1991

The United States has recorded 5,182 confirmed measles cases in 2026 reaching its annual total since 1991 according to data published by Centers for Disease Control and Prevention on November 6. These figures, covering cases reported through November 5 highlight a resurgence of a highly contagious measles that had previously become uncommon in the country.

The latest count represents than twice the 2,289 cases recorded during the whole of 2025. This increase has placed renewed attention on vaccination coverage, outbreak response capacity and the ability of public health authorities to contain transmission across communities.

CDC reported that 562 people had been hospitalised in connection with measles this year representing 11 percent of confirmed cases. CDCs national reporting system also listed four measles-associated deaths in 2026.

CDC reports than 5,000 confirmed cases

CDCs November 6 update showed that 5,182 confirmed cases had been reported nationwide as of November 5. Of these 5,164 were reported across 47 jurisdictions while the remaining cases were associated with visitors.

The term jurisdictions is important because CDCs reporting includes states well as other reporting areas, including District of Columbia and separately listed New York City and New York State. This figure should therefore not be interpreted as 47 states.

The latest number also reflects an increase from the previous CDC update, which reported 4,852 cases as of October 29. The additional 330 cases illustrate the continued scale of transmission being recorded in the surveillance system.

CDCs annual figures are preliminary. May change as health departments update case records and investigations are completed.

Children and teenagers account for 60% of infections

The outbreak is affecting multiple age groups although children and teenagers account for a significant share of reported infections.

According to figures cited in CDCs November 6 update 2,104 cases involved people aged 5 to 19 while 908 cases were reported among children than five. Together these groups represent 59 percent of the national total.

Adults aged 20 and older accounted for 2,132 cases making them the largest single age grouping in the reported figures.

The distribution demonstrates that measles is not exclusively a health issue. Although children represent a proportion of infections adults are also experiencing outbreaks and may require medical assessment, vaccination review or public health follow-up depending on their exposure and immunity status.

Measles can lead to complications, including pneumonia and inflammation of the brain. Young children, pregnant people and individuals with weakened systems are among the groups that can face greater risks from infection.

Vaccination status remains a concern

CDC reported that approximately 96 percent of the confirmed cases involved people who were either unvaccinated or had an unknown vaccination status.

This figure combines two categories. It does not mean that 96 percent of people were confirmed to have refused vaccination. Some individuals may have an unverified vaccination history.

Measles, mumps and rubella vaccine is the tool used to prevent measles infection. Two doses provide protection while high vaccination coverage across communities also helps reduce the likelihood of sustained transmission.

When vaccination coverage falls in communities measles can spread rapidly after an infected person introduces the virus. Measles is airborne and highly contagious making it difficult to contain through contact precautions alone.

Public health authorities therefore rely on vaccination programmes, exposure investigations, isolation guidance and communication with communities to limit further transmission.

Hospitalisations and deaths add pressure to health services

CDC reported 562 measles-related hospitalisations in 2026 equivalent to approximately 11 percent of confirmed cases. Hospital treatment may be necessary when patients develop complications or require medical support.

Measles response can also create demands beyond the treatment of confirmed patients. Hospitals and clinics may need to identify and isolate infectious individuals investigate exposure locations, assess staff immunity and coordinate follow-up for people who may have been exposed.

CDCs national tally lists four measles-associated deaths far in 2026. However the national figure has not always matched the numbers reported by state authorities.

Reuters reported that Pennsylvania and other state-level reporting had identified deaths while CDCs national count relies on National Center, for Health Statistics mortality data. The distinction matters because different reporting systems may update at times and apply different verification processes.

For that reason the figure of four deaths should be taken as the CDCs count reported in the November 6 update. This figure is not a count that reconciles every state report.

Outbreaks spread across jurisdictions

The CDCs data for November 5 showed that 47 jurisdictions had reported cases. The CDC also documented 43 outbreaks during 2026.

A jurisdiction that reports least one case does not always have an active outbreak at the time of publication. These two measures describe aspects of disease surveillance. One is reporting. The other is identified outbreak events.

A large portion of the years cases has been linked to outbreaks. Reuters reported that 4,993 cases 96 percent of the national total were tied to outbreak events.

The spread across locations creates challenges for public health agencies. Local transmission can need responses. These responses depend on community vaccination coverage, population movement and how many people are exposed.

State and local health departments investigate cases and trace contacts to find transmission chains. State and local health departments also issue exposure notifications when infected people have visited places. Those places can be schools, health care facilities or other shared spaces.

US measles elimination status faces renewed attention

The resurgence has raised questions about whether the United States can keep its measles elimination status.

The country was declared to have stopped endemic measles transmission in 2000. Elimination does not mean that no measles cases can ever occur. Imported infections and small outbreaks can still happen, long as sustained transmission is stopped.

The current outbreak pattern has put that status under scrutiny. A long chain of transmission can threaten elimination status if the disease has not become permanently established across the whole country.

The Pan American Health Organization will run a verification process. This process will examine the situation. Decide whether the United States still meets the criteria for measles elimination.

The assessment matters because elimination status shows the countrys ability to stop sustained transmission. It does not just show the number of reported infections.

Implications for healthcare and vaccine supply

The rising case count has effects on healthcare providers, public health agencies and vaccine distribution systems.

Hospitals may have costs for infection‑control procedures, patient isolation, diagnostic testing and exposure management. Pediatric services and emergency departments in communities may also need to coordinate extra public health reporting and follow‑up.

The outbreak may raise demand for MMR vaccination services. This is especially true in communities where coverage's low or where health departments find people who need vaccination.

Vaccine manufacturers, distributors and public procurement agencies may also watch demand and inventory levels as immunisation programmes respond to outbreaks. However the CDCs case figures alone do not show a commercial supply shortage or promise increased revenue for vaccine manufacturers.

For healthcare organisations the immediate issue is keeping staff, infection‑control capacity and access to vaccination services. All of this while continuing medical operations.

What happens next?

The next phase of the outbreak will depend on the ability of state and local health departments to stop transmission improve vaccination coverage and find populations.

The CDCs weekly updates will remain important for tracking changes in case numbers, hospitalisations, deaths and geographic distribution. The national elimination‑status review will also be watched closely. The review could have implications for how the United States measles response's assessed across the Americas.

The 2026 figures show that measles is still a public health risk when community immunity is low. With, than 5,000 confirmed infections reported public health authorities now focus on limiting further transmission protecting vulnerable groups and strengthening routine immunisation.

The outbreak is also a reminder that stopping domestic transmission does not mean vaccination and surveillance can be stopped. Keeping those protections in place is essential to prevent outbreaks.

---